26 tracked 13F filers disclose a position in TRAW as of the latest SEC 13F filings, a combined $6.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.3M | 730K | —Held | Q1 2026 | |
| 2 | Ikarian Capital, LLC | $1.2M | 678K | —Held | Q1 2026 | |
| 3 | ORBIMED ADVISORS LLC | $1.1M | 606K | —Held | Q1 2026 | |
| 4 | Lynx1 Capital Management LP | $472K | 559K | ▲37× Added · +544K sh | Q2 2026 | |
| 5 | Squadron Capital Management LLC | $936K | 512K | ▼−28% Reduced · −202K sh | Q1 2026 | |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | $356K | 195K | —Held | Q1 2026 | |
| 7 | ADAR1 Capital Management, LLC | $282K | 154K | ▼−0.2% Reduced · −333 sh | Q1 2026 | |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $94K | 111K | ▲+44% Added · +34K sh | Q2 2026 | |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | $101K | 55K | →First observed position No prior filed position | Q1 2026 | |
| 10 | VANGUARD FIDUCIARY TRUST CO | $58K | 32K | →First observed position No prior filed position | Q1 2026 | |
| 11 | STATE STREET CORP | $22K | 26K | —Held | Q2 2026 | |
| 12 | JANE STREET GROUP, LLC | $39K | 21K | ▲New +21K sh | Q1 2026 | |
| 13 | TWO SIGMA INVESTMENTS, LP | $35K | 19K | —Held | Q1 2026 | |
| 14 | BlackRock, Inc. | $18K | 10K | —Held | Q1 2026 | |
| 15 | HUNTINGTON NATIONAL BANK | $4K | 5K | ▲New +5K sh | Q2 2026 | |
| 16 | UBS Group AG | $7K | 4K | ▼−48% Reduced · −4K sh | Q1 2026 | |
| 17 | Tower Research Capital LLC (TRC) | $7K | 4K | ▲New +4K sh | Q1 2026 | |
| 18 | MORGAN STANLEY | $7K | 4K | ▲New +4K sh | Q1 2026 | |
| 19 | SBI Securities Co., Ltd. | $1K | 2K | ▲13× Added · +2K sh | Q2 2026 | |
| 20 | Vanguard Global Advisers, LLC | $479 | 262 | →First observed position No prior filed position | Q1 2026 | |
| 21 | FMR LLC | $42 | 23 | ▲12× Added · +21 sh | Q1 2026 | |
| 22 | Cassaday & Co Wealth Management LLC | $6 | 6 | ▼−45% Reduced · −5 sh | Q2 2026 | |
| 23 | ROYAL BANK OF CANADA | $0 | 6 | ▲New +6 sh | Q1 2026 | |
| 24 | JONES FINANCIAL COMPANIES LLLP | $4 | 2 | ▲New +2 sh | Q1 2026 | |
| 25 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $4 | 2 | ▲New +2 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund opened a new position in TRAW and 2 added to an existing one, while 2 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 8 funds | $1.2B |
| REVOLUTION MEDICINES INCRVMD | 8 funds | $761.3M |
| PRAXIS PRECISION MEDICINES IPRAX | 8 funds | $353.7M |
| RELMADA THERAPEUTICS INCRLMD | 8 funds | $154.7M |
| MAZE THERAPEUTICS INCMAZE | 8 funds | $64.7M |
| PALISADE BIO INCPALI | 8 funds | $22.1M |
| BOSTON SCIENTIFIC CORPBSX | 7 funds | $1.0B |
| BRISTOL-MYERS SQUIBB COBMY | 7 funds | $852.1M |
| REGENERON PHARMACEUTICALSREGN | 7 funds | $733.8M |
| DANAHER CORPDHR | 7 funds | $488.4M |
| IONIS PHARMACEUTICALS INCIONS | 7 funds | $471.3M |
| MERCK & CO. INC.MRK | 7 funds | $422.0M |
Ranked by how many of TRAW's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | ORBIMED ADVISORS LLC | 10% Owner | Buy (P) | 598K | $998K |
Connected entities for TRAW
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TRAW/capital-change-brief"
Use Arkolith's capital_change_brief for TRAW. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TRAW. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.